197
Views
6
CrossRef citations to date
0
Altmetric
Review

Treatment options for children and adolescents with inflammatory bowel disease: is granulomonocytapheresis an effective alternative to drug therapy?

, , &
Pages 749-758 | Received 10 Aug 2015, Accepted 08 Jun 2017, Published online: 28 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dongdong Zhang, Yufan Zhu, Yanxia Jin, Natasha Mupeta Kaweme & Youhong Dong. (2021) Leukapheresis and Hyperleukocytosis, Past and Future. International Journal of General Medicine 14, pages 3457-3467.
Read now

Articles from other publishers (5)

Tomotaka Tanaka. (2023) Therapeutic Granulomonocytapheresis as a Non-pharmacologic Treatment Option for Inflammatory Bowel Disease: Efficacy Reports on a Wide Age Range and Disease Profile. Cureus.
Crossref
Yoshiaki Sasaki & Hiroki Kajino. (2021) Granulomonocytapheresis Using the Single-Needle Method for a Girl with Ulcerative Colitis. Case Reports in Medicine 2021, pages 1-3.
Crossref
Xiu-Li Chen, Jing-Wei Mao & Ying-De Wang. (2020) Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future. World Journal of Gastrointestinal Pathophysiology 11:3, pages 43-56.
Crossref
Yoichi Saegusa, Shizuka Mihara, Myonchori Kimu, Aya Kato, Sadahito Kuwao, Toshiharu Mitsuhashi, Katsunori Saionji & Masato Oida. (2018) A Steroid-naive Child with Ulcerative Colitis who Responded to Granulocyte Apheresis顆粒球除去療法が奏功したステロイドナイーブ小児潰瘍性大腸炎の1例. Progress of Digestive Endoscopy 92:1, pages 136-137.
Crossref
Yoko Yokoyama, Koji Kamikozuru, Kenji Watanabe & Shiro Nakamura. (2018) Inflammatory bowel disease patients experiencing a loss of response to infliximab regain long-term response after undergoing granulocyte/monocyte apheresis: A case series. Cytokine 103, pages 25-28.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.